7/12 2021

The Edison Accelerator Program: Strengthening collaboration between the healthtech ecosystem

Datapoints floating
Radiobotics is pleased to announce that we have been selected as one of the 5 Health-Tech companies to work with GE Healthcare & Wayra in the first ever EMEA Edison Accelerator Program along with VineHealth, Legit.Health, Lucida Medical and SPRYT. We truly believe that collaboration is the key to unlock the value that exists in this ecosystem. Working together with GE and EMRAD (a partnership of 7 NHS trusts operating in the East Midlands), we will prove what we can achieve when Radiology AI companies like Radiobotics, Radiology powerhouses like GE and Innovative Healthcare partner like EMRAD can achieve when aligned around a vision to Accelerate Imaging AI Adoption at Scale.Healthcare is an extremely complex industry to operate in and in order to bring significant value, we truly believe that we need the greatest clinician minds coupled with technology innovation to design what the future of healthcare looks like. No single player can do this alone, we need to bring together the greatest minds and break free from the silos which exist within healthcare.The focus of the accelerator is grounded around 3 key pillars which are essential to Imaging AI adoption at scale: innovation, adoption and integration. Each player in the program, from Radiobotics, to GE to EMRAD brings each its unique flavour and twist to these areas, from GE bringing a wealth of experience in integration, EMRAD with a proven track record of digital transformation and adoption in the NHS to Radiobotics with its innovative product offerings.

By joining the accelerator, Radiobotics looks forward to:

• Receiving mentoring on problem validation, business, regulatory and clinical validation, and deployment.
• Participating in joint pilots between Radiobotics & EMRAD.
• Accessing support in customer discovery and product validation.
• Accessing support in adapting, integrating and launching solutions on the Edison marketplace.
• Accessing GE Healthcare global commercial force and customers in various markets.
• Receiving support for clinical studies and regulatory preparation in target geographies.